摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,3,4,4-四氟-己烷 | 648-36-2

中文名称
3,3,4,4-四氟-己烷
中文别名
——
英文名称
3,3,4,4-Tetrafluor-hexan
英文别名
3,3,4,4-Tetrafluorohexane
3,3,4,4-四氟-己烷化学式
CAS
648-36-2
化学式
C6H10F4
mdl
——
分子量
158.139
InChiKey
IXXUFIHVXOCHGZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    92.5±8.0 °C(Predicted)
  • 密度:
    1.086 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    3,4-己二酮 在 sulfur tetrafluoride 、 氢氟酸 作用下, 反应 2.0h, 以84%的产率得到3,3,4,4-四氟-己烷
    参考文献:
    名称:
    Burmakov, A. I.; Stepanov, I. V.; Kunshenko, B. V., Journal of Organic Chemistry USSR (English Translation), 1982, p. 1009 - 1013
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Partially fluorinated alkanols having a tertiary structure
    申请人:Allied-Signal Inc.
    公开号:US05254755A1
    公开(公告)日:1993-10-19
    Novel partially fluorinated alkanes having the Formula: ##STR1## wherein each R is the same or different and is selected from the group consisting of CF.sub.3, CHF.sub.2, CH.sub.2 F, and CH.sub.3 CF.sub.2, and R' is an alkyl or fluoroalkyl group having 1 to 6 carbon atoms have utility as solvents in a variety of industrial cleaning applications including cold cleaning, dry cleaning, and defluxing of printed circuit boards.
    具有以下式子的部分氟化烷类小说:##STR1## 其中每个R相同或不同,且选自CF.sub.3,CHF.sub.2,CH.sub.2 F和CH.sub.3 CF.sub.2的群组,而R'是具有1到6个碳原子的烷基或氟烷基。它们在各种工业清洗应用中具有溶剂的实用性,包括冷清洗、干洗和印刷电路板的去焊剂。
  • Partially fluorinated alkanes having a tertiary structure
    申请人:Allied-Signal Inc.
    公开号:US05059728A1
    公开(公告)日:1991-10-22
    Novel partially fluorinated alkanes having the Formula: ##STR1## wherein each R is the same or different and is selected from the group consisting of CF.sub.3, CHF.sub.2, CH.sub.2 F, and CH.sub.3 CF.sub.2, and R' is an alkyl or fluoroalkyl group having 1 to 6 carbon atoms with the proviso that when each R is CF.sub.3, R' is not CF.sub.3 (CF.sub.2).sub.2 -, CH.sub.3 CF.sub.2 -, or CF.sub.3 have utility as solvents in a variety of industrial cleaning applications including cold cleaning, dry cleaning, and defluxing of printed circuit boards.
    具有以下式子的部分氟代烷类新型化合物:##STR1## 其中每个R相同或不同,可从CF.sub.3,CHF.sub.2,CH.sub.2 F和CH.sub.3 CF.sub.2组中选择,R'是具有1到6个碳原子的烷基或氟代烷基,但当每个R为CF.sub.3时,R'不是CF.sub.3(CF.sub.2).sub.2-,CH.sub.3 CF.sub.2-或CF.sub.3。这些化合物可用作溶剂,适用于各种工业清洗应用,包括冷清洗、干洗和印刷电路板的除通。
  • Method of cleaning using partially fluorinated alkanes having a tertiary
    申请人:Allied-Signal Inc.
    公开号:US05118359A1
    公开(公告)日:1992-06-02
    Novel partially fluorinated alkanes having the Formula: ##STR1## wherein each R is the same or different and is selected from the group consisting of CF.sub.3, CHF.sub.2, CH.sub.2 F, and CH.sub.3 CF.sub.2, and R' is an alkyl or fluoroalkyl group having 1 to 6 carbon atoms with the proviso that when each R is CF.sub.3, R' is not CF.sub.3 (CF.sub.2).sub.2 --, CF.sub.3 CF.sub.2 --, or CF.sub.3 have utility as solvents in a variety of industrial cleaning applications including cold cleaning, dry cleaning, and defluxing of printed circuit boards.
    部分氟代烷类小说具有以下化学式:##STR1##其中每个R相同或不同,选择自CF.sub.3,CHF.sub.2,CH.sub.2F和CH.sub.3CF.sub.2的群组,并且R'是具有1至6个碳原子的烷基或氟代烷基,但当每个R为CF.sub.3时,R'不是CF.sub.3(CF.sub.2).sub.2-,CF.sub.3CF.sub.2-或CF.sub.3。在各种工业清洗应用中,包括冷清洗,干洗和打通印刷电路板中,具有溶剂的效用。
  • Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
    申请人:Ralston Hamilton Stuart
    公开号:US20070027112A1
    公开(公告)日:2007-02-01
    The present invention pertains to certain ketones and reduced ketones and derivatives thereof which, inter alia, inhibit osteoclast survival, formation, and/or activity; and/or inhibit bone resorption, and more particularly to compounds of the formulae: (1) (2) wherein: Ar 1 is independently a biphenyl, phenanthryl, fluorenyl, or carbazolyl, and is optionally substituted; R alk is independently a C 2-10 alkylene group, and is optionally substituted; —OR O , if present, is independently —OH or —OR K ; —OR K , if present, is independently selected from: —O—R K1 ; —O—C(═O)R K2 ; —O—C(═O)OR K3 ; —O—S(═O)2OR K4 ; Q is independently —OH or —OR OT ; wherein: —OR OT , if present, is independently selected from: —O—R E1 ; —O—C(═O)—R E2 ; —O—C(═O)—O—R E3 ; —O—C(═O)—O—SO 3 R E4 ; —O—C(═O)—O—(CH 2 ) n —COOR E5 ; —O—C(═O)—(CH 2 ) n —NR N1 R N2 ; —O—C(═O)—(CH 2 ) n —NH—C(═O)R E6 ; —O—C(═O)—(CH 2 ) n —C(═O)—NR N3 R N4 ; —O—P(═O)(OR E7 )(OR E8 ); —O—R PA ; R PA , if present, is an organic group which incorporates a phosphonic acid group; with the proviso A that if —OR OT is —O—R E1 , then R E1 is not a phenyl group substituted with a sulfonyl group; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, or prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit osteoclast survival, formation, and/or activity, and to inhibit conditions mediated by osteoclasts and/or characterised by bone resorption, in the treatment of bone disorders such as osteoporosis, rheumatoid arthritis, cancer associated bone disease, Paget's disease, aseptic loosening of prosthetic implants, and the like; and/or in the treatment of conditions associated with inflammation or activation of the immune system.
    本发明涉及某些酮和还原酮及其衍生物,其中包括抑制破骨细胞的存活、形成和/或活性;和/或抑制骨吸收的化合物,更具体地说,是以下式子的化合物:(1)(2) 其中:Ar1独立地是联苯基,菲基,芴基或咔唑基,且可以被取代;Ralk独立地是C2-10烷基,且可以被取代;-ORO,如果存在,则独立地是-OH或-ORK;-ORK,如果存在,则独立地选自:-O-RK1;-O-C(═O)-RK2;-O-C(═O)-ORK3;-O-S(═O)2ORK4;Q独立地是-OH或-OROT;其中:-OROT,如果存在,则独立地选自:-O-RE1;-O-C(═O)-RE2;-O-C(═O)-O-RE3;-O-C(═O)-O-SO3RE4;-O-C(═O)-O-(CH2)n-COORE5;-O-C(═O)-(CH2)n-NRN1RN2;-O-C(═O)-(CH2)n-NH-C(═O)RE6;-O-C(═O)-(CH2)n-C(═O)-NRN3RN4;-O-P(═O)(ORE7)(ORE8);-O-RPA;如果存在RPA,则是包含膦酸基的有机基团;但前提是如果-OROT是-O-RE1,则RE1不是取代有磺酰基的苯基;以及其药学上可接受的盐、溶剂化合物、酰胺、酯、醚、化学保护形式或前药。本发明还涉及包含这种化合物的制药组合物,以及这种化合物和组合物的使用,无论是在体内还是体外,以抑制破骨细胞的存活、形成和/或活性,并抑制由破骨细胞介导和/或特征为骨吸收的疾病,如骨质疏松症、类风湿性关节炎、癌症相关骨病、帕吉特病、假体松动等;和/或用于治疗与炎症或免疫系统激活相关的疾病。
  • Fluorine-containing alpha,omega-bifunctional compounds and process for their production
    申请人:SAGAMI CHEMICAL RESEARCH CENTER
    公开号:EP0383141A2
    公开(公告)日:1990-08-22
    A fluorine-containina α,ω-bifunctional compound havina the formula: wherein each of R1 and R2 independently is a hydrogen atom, an alkyl group or an aralkyl group; X is -COOH, -COOR3, -COY or -NCO, wherein R3 is an alkyl group or an aralkyl group and Y is a halogen atom or N3; and n is an integer of at least 1 provided that when X is -COOH, n is an integer of at least 4.
    一种含氟α,ω-双官能团化合物,其式如下 其中 R1 和 R2 各自独立地为氢原子、烷基或芳烷基;X 为-COOH、-COOR3、-COY 或-NCO,其中 R3 为烷基或芳烷基,Y 为卤素原子或 N3;n 至少为 1 的整数,条件是当 X 为-COOH 时,n 至少为 4 的整数。
查看更多